[1] |
Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation. Handb Clin Neurol, 2018, 147: 293-305.
doi: B978-0-444-63233-3.00019-1
pmid: 29325618
|
[2] |
Illingworth MA, Meyer E, Chong WK, Manzur AY, Carr LJ, Younis R, Hardy C, McDonald F, Childs AM, Stewart B, Warren D, Kneen R, King MD, Hayflick SJ, Kurian MA. PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood- onset disease. Mol Genet Metab, 2014, 112(2): 183-189.
doi: 10.1016/j.ymgme.2014.03.008
pmid: 24745848
|
[3] |
Spaull RVV, Soo AKS, Hogarth P, Hayflick SJ, Kurian MA. Towards precision therapies for inherited disorders of neurodegeneration with brain iron accumulation. Tremor Other Hyperkinet Mov (N Y), 2021, 11: 51.
doi: 10.5334/tohm.661
pmid: 34909266
|
[4] |
Tan JQ, Yan TZ, Chang RN, Yuan DJ, Pan LZ, Cai R. Analysis of PLA2G6 gene variant in a family affected with infantile neuroaxonal dystrophy. Chin J Med Genet, 2020, 37(1): 21-24.
|
|
谭建强, 严提珍, 畅荣妮, 袁德健, 潘莉珍, 蔡稔. 一个婴儿神经轴索营养不良家系的基因变异分析. 中华医学遗传学杂志, 2020, 37(1): 21-24.
|
[5] |
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med, 2015, 17(5): 405-424.
doi: 10.1038/gim.2015.30
pmid: 25741868
|
[6] |
Wang BT, Wu D, Tang JL. Infantile neuroaxonal dystrophy caused by PLA2G 6 gene mutation in a chinese patient:a case report. Exp Ther Med, 2018, 16(2): 1290-1294.
|
[7] |
高志杰, 姜玉武, 吴晔, 王静敏, 熊晖, 袁云, 吴希如. 婴儿神经轴索营养不良临床与分子遗传学研究. 中国实用儿科杂志, 2008, 23(5): 371-373.
|
[8] |
Zhang PP, Gao ZJ, Wang JM, Jiang YW, Zhang F, Xiao JX, Wang S, Yang YL, Zhang YH, Xiong H. Follow-up study and genetic analysis of chinese patients with infantile neuroaxonal dystrophy. J Appl Clin Pediatr, 2012, 27(9): 692-696.
|
|
张平平, 高志杰, 王静敏, 姜玉武, 张锋, 肖江喜, 王爽, 杨艳玲, 张月华, 熊晖. 中国婴儿神经轴索营养不良患儿临床随访及分子遗传学研究. 实用儿科临床杂志, 2012, 27(9): 692-696.
|
[9] |
Li J, Peng LY, Shu XM. Clinical features and PLA2G6 gene mutations analysis of two siblings with infantile neuroaxonal dystrophy. J Clin Pediatr, 2019, 37(11): 820-823.
|
|
李娟, 彭龙英, 束晓梅. 两例同胞婴儿神经轴索营养不良临床特征及PLA2G6基因分析. 临床儿科杂志, 2019, 37(11): 820-823.
|
[10] |
Ma XW, Zhu LN, Gu RJ, Hou Y, Feng ZC. Clinical and PLA2G6 gene mutations analysis of infantile neuroaxonal dystrophy in one child. J Clin Pediatr, 2018, 36(4): 252-255.
|
|
马秀伟, 朱丽娜, 辜蕊洁, 侯豫, 封志纯. 婴儿神经轴索营养不良 1 例临床和 PLA2G6基因突变分析. 临床儿科杂志, 2018, 36(4): 252-255.
|
[11] |
Lu HZ, Chen R, Chen YH. A homozygous mutation in PLA2G6 gene causing infantile neuroaxonal dystrophy: a case report. J Clin Pediatr, 2017, 35(11): 820-822, 825.
|
|
卢洪珠, 陈荣, 陈燕惠. PLA2G6基因纯合突变致婴儿神经轴索营养不良1例报告. 临床儿科杂志, 2017, 35(11): 820-822, 825.
|
[12] |
Luo J, Wang BC, Zhang YZ, Huang ZL, Huang YF, Zheng F. Mutation testing of PLA2G6 gene in a Chinese family with infantile neuroaxonal dystrophy. Chin J Clin Lab Sci, 2016, 34(4): 268-272.
|
|
罗晶, 汪必成, 张元珍, 黄朱亮, 黄一芳, 郑芳. 婴儿神经轴索营养不良患者PLA2G6基因的突变检测. 临床检验杂志, 2016, 34(4): 268-272.
|
[13] |
Wang JL, Wu W, Chen XF, Zhang L, Wang XM, Dong GP. A novel homozygous mutation in PLA2G6 gene causes infantile neuroaxonal dystrophy in a case. Chin J Med Genet, 2016, 33(1): 64-67.
|
|
王金玲, 吴蔚, 陈雪峰, 张黎, 王秀敏, 董关萍. PLA2G6基因纯合突变致婴儿神经轴索营养不良一例. 中华医学遗传学杂志, 2016, 33(1): 64-67.
|
[14] |
Hao Y, Chen DW, Zhang GR, Zhang ZG, Liu XJ, Zhou P, Wei ZL, Xu XF, He XJ, Xing LX, Lv MR, Ji DM, Chen BL, Zou WW, Wu H, Liu YJ, Cao YX. Successful clinical application of pre-implantation genetic diagnosis for infantile neuroaxonal dystrophy. Exp Ther Med, 2020, 19(2): 956-964.
doi: 10.3892/etm.2019.8302
pmid: 32010257
|
[15] |
Zheng XL, Zhou SZ, Li WH. Phospholipase A2-associated neurodegenerative disease: a report of 5 cases and literature review in China. Zhong Guo Shi Yong Er Ke Za Zhi, 2021, 36(10): 783-788.
|
|
郑小兰, 周水珍, 李文辉. 非钙依赖型磷脂酶A2相关性神经变性病5例并国内文献复习. 中国实用儿科杂志, 2021, 36(10): 783-788.
|
[16] |
Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, Vardi G, Shorer Z, Levy R, Galil A, Elbedour K, Birk OS. PLA2G 6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet, 2006, 79(5): 942-948.
doi: 10.1086/508572
|
[17] |
Chen SM, Xiong J, Deng XL, Pang N, Wang XL, Zhang W, Yin F. The clinical characteristics and molecular genetics of infantile neuroaxonal dystrophy: the current research progress. J Chin Physician, 2017, 19(8): 1121-1124.
|
|
陈施梦, 熊娟, 邓小鹿, 庞楠, 王晓乐, 张文, 尹飞. 婴儿神经轴索营养不良临床特点及分子遗传学的研究进展. 中国医师杂志, 2017, 19(8): 1121-1124.
|
[18] |
Malley KR, Koroleva O, Miller I, Sanishvili R, Jenkins CM, Gross RW, Korolev S. The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization. Nat Commun, 2018, 9(1): 765.
doi: 10.1038/s41467-018-03193-0
|
[19] |
Iodice A, Spagnoli C, Salerno GG, Frattini D, Bertani G, Bergonzini P, Pisani F, Fusco C. Infantile neuroaxonal dystrophy and PLA2G6-associated neurodegeneration: an update for the diagnosis. Brain Dev, 2017, 39(2): 93-100.
doi: 10.1016/j.braindev.2016.08.012
|
[20] |
Engel LA, Jing Z, O'Brien DE, Sun MY, Kotzbauer PT. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One, 2010, 5(9): e12897.
doi: 10.1371/journal.pone.0012897
|
[21] |
Ndayisaba A, Kaindlstorfer C, Wenning GK. Iron in neurodegeneration-cause or consequence? Front Neurosci, 2019, 13: 180.
doi: 10.3389/fnins.2019.00180
|
[22] |
Timmermann L, Pauls KAM, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain, 2010, 133(Pt 3): 701-712.
doi: 10.1093/brain/awq022
pmid: 20207700
|
[23] |
Pearson TS, Gupta N, San Sebastian W, Imamura-Ching J, Viehoever A, Grijalvo-Perez A, Fay AJ, Seth N, Lundy SM, Seo Y, Pampaloni M, Hyland K, Smith E, de Oliveira Barbosa G, Heathcock JC, Minnema A, Lonser R, Elder JB, Leonard J, Larson P, Bankiewicz KS. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun, 2021, 12(1): 4251.
doi: 10.1038/s41467-021-24524-8
pmid: 34253733
|